A detailed history of Private Trust CO Na transactions in Genmab A/S stock. As of the latest transaction made, Private Trust CO Na holds 700 shares of GMAB stock, worth $14,812. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Previous 580 20.69%
Holding current value
$14,812
Previous $14,000 21.43%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.84 - $28.48 $2,860 - $3,417
120 Added 20.69%
700 $17,000
Q2 2024

Jul 23, 2024

BUY
$25.13 - $30.27 $376 - $454
15 Added 2.65%
580 $14,000
Q1 2024

Apr 24, 2024

BUY
$26.43 - $32.77 $2,669 - $3,309
101 Added 21.77%
565 $16,000
Q3 2023

Oct 18, 2023

BUY
$35.27 - $42.24 $352 - $422
10 Added 2.2%
464 $16,000
Q2 2023

Jul 28, 2023

SELL
$37.4 - $42.94 $1,757 - $2,018
-47 Reduced 9.38%
454 $17,000
Q1 2023

Apr 12, 2023

SELL
$34.88 - $43.22 $12,731 - $15,775
-365 Reduced 42.15%
501 $18,000
Q4 2022

Jan 18, 2023

BUY
$33.8 - $47.06 $2,568 - $3,576
76 Added 9.62%
866 $0
Q3 2022

Oct 17, 2022

BUY
$31.52 - $373.61 $4,444 - $52,679
141 Added 21.73%
790 $25,000
Q2 2022

Sep 16, 2022

BUY
$26.83 - $38.57 $17,412 - $25,031
649 New
649 $21,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.9B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.